Press What’s news at AbelsonTaylor Group
Select category
Moving Into 2024
Applying his background in pharmacology, Jeff Berg, President of AbelsonTaylor Group, discusses a particularly exciting use of AI in drug discovery that is tackling one of biology’s biggest challenges – predicting the 3D shape of proteins and designing them from scratch. Read more at https://www.pharmalive.com/healthcare-agency-roundtable-2024-moving-into-2025/
Media Contact:
Recent Posts
Tim Moore Joins AbelsonTaylor Group as VP, Creative Director
AbelsonTaylor Group, a leading independent healthcare marketing and communications agency, is pleased to announce that award-winning creative leader Tim Moore...
Read Press Read more Tim Moore Joins AbelsonTaylor Group as VP, Creative DirectorAI for Beginners Podcast: “Customer Panel? Too Slow. Here’s the Synthetic Version”
AbelsonTaylor Group’s Chief Creative Officer, Janet Barker-Evans joined Dietmar Fischer on the Beginner’s Guide to AI podcast to break down how...
In the News Read more AI for Beginners Podcast: “Customer Panel? Too Slow. Here’s the Synthetic Version”Medical marketing leaders on how the new Omnicom will reshape the fabled Chicago ad scene
Janet Barker-Evans, EVP–Chief Creative Officer at AbelsonTaylor Group, offers MM+M’s Jack O’Brien a candid and thoughtful perspective on how Omnicom’s...
In the News Read more Medical marketing leaders on how the new Omnicom will reshape the fabled Chicago ad sceneConnect with us
Find out what's top of mind for the people reimagining health and wellness advertising.